UniProtKB/SwissProt variant VAR

Variant information

Variant position:

703

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Phenylalanine (F) to Serine (S) at position 703 (F703S, p.Phe703Ser).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and aromatic (F) to small size and polar (S)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Involvement in disease:

Distal spinal muscular atrophy, autosomal recessive, 4 (DSMA4) [MIM:611067]: A neuromuscular disorder. Distal spinal muscular atrophy, also known as distal hereditary motor neuronopathy, represents a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. DSMA4 is characterized by childhood onset, generalized muscle weakness and atrophy with denervation and normal sensation. Bulbar symptoms and pyramidal signs are absent. {ECO:0000269|PubMed:17564964}. Note=The disease is caused by mutations affecting the gene represented in this entry.

The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:

In DSMA4; stability and intracellular location affected severely impairing the NF-kappa-B transduction pathway.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs63750315 [ dbSNP | Ensembl ]

Sequence information

Variant position:

703

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1062

The length of the canonical sequence.

Location on the sequence:

IRPPLLVDKIVCRELRDPGS F LLIYLNEFHSAVGAYTFQAS

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         IRPPLLVDKIVCRELRDPGSFLLIYLNEFHSAVGAYTFQAS

Mouse                         IRPPLLVDKIVCRELRDPGSFLLIYLNEFHSAVGAYTFQAS

Rat                           IRPPLLVDKIVCRELRDPGSFLLIHLNEFHSAVGAYTFQAS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1062	Pleckstrin homology domain-containing family G member 5
Domain	640 – 740	PH

Literature citations

The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset.
Maystadt I.; Rezsoehazy R.; Barkats M.; Duque S.; Vannuffel P.; Remacle S.; Lambert B.; Najimi M.; Sokal E.; Munnich A.; Viollet L.; Verellen-Dumoulin C.;
Am. J. Hum. Genet. 81:67-76(2007)
Cited for: VARIANT DSMA4 SER-703;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O94827: Variant p.Phe703Ser